Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Richards

Showing results (571-580 of 678) with videos related to

Pageof 68
Sort By:
Journal of Intensive Care Medicine|March 22, 2021
Critical Care Transport of Patients With COVID-19Michael A Frakes, Jeremy B Richards, Michael N Cocchi, et al.
Psychopharmacology|July 4, 2012
Effects of mu opioid receptor antagonism on cognition in obese binge-eating individualsSamuel R Chamberlain, Karin Mogg, Brendan P Bradley, et al.
Annals of the Rheumatic Diseases|June 26, 2012
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled studyMark C Genovese, Patrick Durez, Hanno B Richards, et al.
Arthritis and Rheumatism|February 1, 2007
Autoantibodies to RNA helicase A: a new serologic marker of early lupusYoshioki Yamasaki, Sonali Narain, Hideo Yoshida, et al.
Journal of Economic Entomology|January 24, 2018
Blends of Pheromones, With and Without Host Plant Volatiles, Can Attract Multiple Species of Cerambycid Beetles SimultaneouslyL M Hanks, J A Mongold-Diers, T H Atkinson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 13, 2000
Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processingL D Fricker, A A McKinzie, J Sun, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 27, 2017
A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's diseaseSarah L Marrinan, Tal Otiker, Lakshmi S Vasist, et al.
Cancer|November 15, 2007
Cancer in Appalachia, 2001-2003Phyllis A Wingo, Thomas C Tucker, Patricia M Jamison, et al.
The Journal of Rheumatology|January 17, 2014
One-year efficacy and safety results of secukinumab in patients with rheumatoid arthritis: phase II, dose-finding, double-blind, randomized, placebo-controlled studyMark C Genovese, Patrick Durez, Hanno B Richards, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 10, 2020
Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III StudyAtul Deodhar, Ricardo Blanco, Eva Dokoupilová, et al.
Pageof 68

Showing results (571-580 of 678) with videos related to

Sort By:
Pageof 68
Journal of Intensive Care Medicine|March 22, 2021
Critical Care Transport of Patients With COVID-19Michael A Frakes, Jeremy B Richards, Michael N Cocchi, et al.
Psychopharmacology|July 4, 2012
Effects of mu opioid receptor antagonism on cognition in obese binge-eating individualsSamuel R Chamberlain, Karin Mogg, Brendan P Bradley, et al.
Annals of the Rheumatic Diseases|June 26, 2012
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled studyMark C Genovese, Patrick Durez, Hanno B Richards, et al.
Arthritis and Rheumatism|February 1, 2007
Autoantibodies to RNA helicase A: a new serologic marker of early lupusYoshioki Yamasaki, Sonali Narain, Hideo Yoshida, et al.
Journal of Economic Entomology|January 24, 2018
Blends of Pheromones, With and Without Host Plant Volatiles, Can Attract Multiple Species of Cerambycid Beetles SimultaneouslyL M Hanks, J A Mongold-Diers, T H Atkinson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 13, 2000
Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processingL D Fricker, A A McKinzie, J Sun, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 27, 2017
A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's diseaseSarah L Marrinan, Tal Otiker, Lakshmi S Vasist, et al.
Cancer|November 15, 2007
Cancer in Appalachia, 2001-2003Phyllis A Wingo, Thomas C Tucker, Patricia M Jamison, et al.
The Journal of Rheumatology|January 17, 2014
One-year efficacy and safety results of secukinumab in patients with rheumatoid arthritis: phase II, dose-finding, double-blind, randomized, placebo-controlled studyMark C Genovese, Patrick Durez, Hanno B Richards, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 10, 2020
Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III StudyAtul Deodhar, Ricardo Blanco, Eva Dokoupilová, et al.
Pageof 68